Retraction Note: BMC Cancer 20, 681 (2020)
https://doi.org/10.1186/s12885-020-07167-8
The Editor has retracted this article. After publication, concerns were raised regarding highly similar images in Fig. 2a (24 h, DFX 10 μm and DFX 100 μM), which the authors addressed by a Correction [1]. However, further concerns have been identified by the publisher, specifically:
Fig. 3c and 3i 0h and 24h control images appear to be the same.
Fig. 3c 50 and 100 uM group 0h images appear highly similar (flipped horizontally)
The authors have also found three other misused images in Fig. 3c (NSC23766 50 µM 0h) and i (ML141 20 µM and 40 µM 0h), and incorrect errors bars in the data presented in Fig. 4a.
The Editor therefore no longer has confidence in the presented data.
All authors agree to this retraction.
References
Amano S, Kaino S, Shinoda S, et al. Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox. BMC Cancer. 2023;23:582. https://doi.org/10.1186/s12885-023-11091-y.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Amano, S., Kaino, S., Shinoda, S. et al. Retraction Note: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox. BMC Cancer 23, 1218 (2023). https://doi.org/10.1186/s12885-023-11677-6
Published:
DOI: https://doi.org/10.1186/s12885-023-11677-6